Protocadherin alpha 3 (PCDHA3) (Middle Region) Peptide
-
- Target See all PCDHA3 products
- PCDHA3 (Protocadherin alpha 3 (PCDHA3))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ATATVLVSLV ESGQAPKASS QASAGATGPE AALVDVNVYL IVAICAVSSL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PCDHA3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PCDHA3 (Protocadherin alpha 3 (PCDHA3))
- Background
-
PCDHA3 is a potential calcium-dependent cell-adhesion protein. It may be involved in the establishment and maintenance of specific neuronal connections in the brain.
Alias Symbols: PCDH-ALPHA3
Protein Size: 950 - Molecular Weight
- 104 kDa
- Gene ID
- 56145
- NCBI Accession
- NM_018906, NP_061729
- UniProt
- Q9Y5H8
-